Emmanuel J. Simons
Chief Executive Officer bij AKOUOS
Oorsprong van het eerstegraads netwerk van Emmanuel J. Simons
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
31
| Subsidiary | Biotechnology | 31 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Emmanuel J. Simons via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Investor Relations Contact | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | President | |
| VERICEL CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| OSIRIS THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| BELLICUM PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SHIRE | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Graduate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| Southern Utah University | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Undergraduate Degree | |
LifeNet Health, Inc.
 LifeNet Health, Inc. Medical/Nursing ServicesHealth Services LifeNet Health, Inc. operates as a full-service organ donation agency and tissue banking system. It offers cardiac, vascular, sports medicine, general orthopedics and trauma, craniomaxillofacial, spine, dental, plastic and reconstructive surgical services. The company was founded in 1982 and is headquartered in Virginia Beach, VA. | Medical/Nursing Services | Corporate Officer/Principal | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Private Equity Investor Private Equity Investor | |
The American Chamber of Commerce in Japan
 The American Chamber of Commerce in Japan Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Japan is a Chamber of Commerce. The non-profit company is based in Minato-ku, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
American Liver Foundation
 American Liver Foundation Miscellaneous Commercial ServicesCommercial Services American Liver Foundation engages in facilitating, advocating and promoting education, support, and research for the prevention, treatment, and cure of liver disease. It educates patients, policymakers and the public and provides grants to early-career researchers to help find a cure for all liver diseases. The company was founded in 1976 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Eli Lilly Italia SpA
 Eli Lilly Italia SpA Pharmaceuticals: MajorHealth Technology Eli Lilly Italia SpA manufactures pharmaceutical products. The company was founded by Colonel Eli Lilly in 1876 and is headquartered in Sesto Fiorentino, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
| Life Sciences Advisory LLC | Chief Executive Officer | ||
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Chief Executive Officer | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| Lund University School of Economics & Management | College/University | Undergraduate Degree | |
| Cruz Blanca Initiative, Inc. | Founder | ||
| DICE THER | Biotechnology | President | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | President | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Chairman Director/Board Member | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Grace Science Foundation
 Grace Science Foundation Miscellaneous Commercial ServicesCommercial Services Grace Science Foundation is a biotechnology company that was founded in 2017 by Matt Wilsey and Dr. Carolyn Bertozzi. The private company is based in San Francisco, CA. The company focuses on developing novel therapies based on the function of NGLY1, a key enzyme involved in proteostasis. Grace Science Foundation's deep knowledge of the NGLY1 pathway enables them to identify new ways of treating NGLY1 deficiency as well as more common diseases. | Miscellaneous Commercial Services | Consultant / Advisor | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Armis Biopharma, Inc.
 Armis Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Armis Biopharma, Inc. is a privately held biopharmaceutical company based in Fort Collins, CO. The company is focused on developing and commercializing products that reduce the risk of infectious disease, decontaminate chemical warfare agents, and provide differentiated medical devices. The company was founded by Edwin D. Neas and has been led by CEO Ted E. Ziemann since 2000. | Pharmaceuticals: Major | Director/Board Member | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Founder Founder | |
| 501 ACQU | Financial Conglomerates | Chief Executive Officer | |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Founder | |
| 5am Partners Vi LLC | Corporate Officer/Principal | ||
| POIT BIOP | Pharmaceuticals: Major | President | |
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
Precede Biosciences, Inc.
 Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Miscellaneous Commercial Services | Director/Board Member | |
Novira Therapeutics LLC
 Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Ierland | 3 |
| India | 2 |
| Japan | 2 |
| Italië | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 5 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 145 |
| Independent Dir/Board Member | 56 |
| Corporate Officer/Principal | 51 |
| Chief Tech/Sci/R&D Officer | 24 |
| President | 16 |
Sterkste connecties
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Heather Elizabeth Preston | 34 |
| Kush Parmar | 32 |
| Vicki Sato | 28 |
| Chris Smith | 21 |
| Sona Saira Ramasastry | 19 |
| Arthur Tzianabos | 15 |
| Philip Johnson | 13 |
| Alan K. Smith | 12 |
| Luk Vandenberghe | 9 |
| Rabia Ozden | 9 |
| Kathleen Reape | 7 |
| Jennifer A. Wellman | 7 |
| Gregory Robinson | 6 |
| Sachiyo Minegishi | 5 |
- Beurs
- Insiders
- Emmanuel J. Simons
- Bedrijfsconnecties
